Cancer News and Research

Latest Cancer News and Research

cT3 prostate cancer is operable

New findings from Mayo Clinic indicate that cT3 prostate cancer, a disease in which the cancer has spread locally from inside the prostate to immediately outside it, is operable and has 15-year cancer survival rates of almost 80 percent.

3 Apr 2005

Cranberry juice may help protect against heart disease

Protection against a wide variety of diseases is among the many benefits of a diet high in whole fruits and vegetables. Cranberries over the years have been identified with preventing or ameliorating urinary tract infections and playing a positive role gum disease, ulcers and even cancer.

3 Apr 2005

Sea floor may yield disease cures

On Monday, the Harbor Branch drug discovery group will begin a 2-week expedition to explore the Straits of Florida in search of organisms that produce chemicals with the potential to cure diseases such as cancer and Alzheimer's.

3 Apr 2005

Late developers more at risk from sexually transmitted disease

Researchers at the Academic Unit of Obstetrics and Gynaecology, St Mary's Hospital, Manchester, UK, have found that late developers may run a higher risk of infection than sexually mature younger teens.

From The University of Manchester 3 Apr 2005

Parents drugs, alcohol and tobacco use harm their children's futures

A white paper - Family Matters: Substance Abuse and the American Family - released by The National Centre on Addiction and Substance Abuse (CASA) at Columbia University, says parents who use illegal drugs, abuse alcohol and use tobacco put half the nation's children - more than 35 million of them - at greater risk of substance abuse and of physical and mental illnesses.

30 Mar 2005

Construction will enable pSivida to increase BrachySil production

Global nanotechnology company pSivida Limited has announced that it's UK manufacturing partner, Atomising Systems Ltd ("ASL"), has reached a key milestone in the manufacture of BrachySil, its lead product, by completing construction of a state of the art dedicated cleanroom facility to GMP specifications at its Sheffield plant in the United Kingdom. ASL is a world leader in high temperature atomising technology.

30 Mar 2005

Mesoblast moves towards adult stem cell human trials

Exciting Australian adult stem cell company, Mesoblast Limited, today announced that it is set to begin the first human clinical trials using its specialist adult stem cells for orthopaedic and cardiovascular diseases.

30 Mar 2005

Too much iron could increase cancer risk

New U.S. research suggests that eating a lot of iron-rich foods may increase the risk of cancer. The research raises questions about fortifying foods with the mineral.

30 Mar 2005

New drug to treat chronic hepatitis B

The U.S. Food and Drug Administration (FDA) has given approval for a new drug to treat the potentially life-threatening disease Chronic hepatitis B.

30 Mar 2005

Medication that both stimulates appetite and reduces metabolic rate

Scientists at Oregon Health & Science University, in collaboration with Neurocrine Biosciences Inc., have successfully tested a research medication that both stimulates appetite and reduces metabolic rate in preclinical trials.

30 Mar 2005

First North American trial to evaluate the role of an aromatase inhibitor in the prevention of breast cancer

Today, a new clinical trial evaluating a novel approach to breast cancer prevention launched in the United States and Canada. Called the ExCel research study, this is the first North American clinical trial to evaluate the role of an aromatase inhibitor in the prevention of breast cancer.

30 Mar 2005

Avoiding risks of skin cancer from ultraviolet radiation (UVR)

Cancer Research UK has launched the SunSmart Campaign for 2005 and NRPB strongly supports the health promotion messages in the campaign.

30 Mar 2005

Vical Incorporated issued two Canadian patents

Vical Incorporated announced today the issuance of two Canadian patents on the company's core technology, which involves direct administration of polynucleotide genetic material such as DNA or RNA.

29 Mar 2005

Bioniche receives European patent

Bioniche Life Sciences Inc., a research-based, technology-driven human and animal health biopharmaceutical company, today announced that it has had an additional European patent granted by the European Patent Office (EPO) on its core mycobacterial cell wall technology.

29 Mar 2005

Grapes inhibit cancer growth

Components in grapes, including some newly identified ones, work together to dramatically inhibit an enzyme crucial to the proliferation of cancer cells, say scientists at the University of Illinois at Urbana-Champaign.

29 Mar 2005

Herceptin - more powerful treatment for patients with HER-2-positive breast cancer

A new use of the drug Herceptin appears to offer a much more powerful treatment advantage than expected for patients with HER-2-positive breast cancer, say researchers at The University of Texas M. D. Anderson Cancer Center.

29 Mar 2005

Depression and anxiety affects one in two breast cancer patients

Almost half of all women with early breast cancer experience depression or anxiety in their first year after diagnosis, reveals a study published in the current issue of the British Medical Journal.

29 Mar 2005

Scientists out cancer cells in permanent coma

Scientists funded by Marie Curie Cancer Care and the Association for International Cancer Research have made an unexpected discovery that could point the way to a completely new approach to treating cancer.

29 Mar 2005

US Genome Project planned to beat cancer

In a project expected to cost $US1.35 billion over nine years, the United States Government's proposed "Human Cancer Genome Project", will open a new front in the battle against cancer, say US health officials.

28 Mar 2005

Onconase granted orphan drug status for malignant mesothelioma in Australia

Alfacell Corporation has announced that the Therapeutic Goods Administration (TGA) in Australia has granted Onconase (ranpirnase) Orphan Drug status for the indication of malignant mesothelioma (MM). Onconase is also designated as an Orphan Drug for MM in Europe.

28 Mar 2005